Amgen to halt Epogen manufacturing at Colorado plant; 220 jobs to go
220 jobs will be cut as Amgen says it intends to suspend all manufacturing operations at its Epogen (Epoetin alfa) facility Colorado, US.
Archives for February 4, 2014
Life Tech takeover gives Thermo 'leading brands' says analyst
Thermo Fisher Scientific completed its takeover of Life Technologies last night, just two days after the US Federal Trade Commission (FTC) approved the $13.6bn deal.
Merck & Co. to discover 'smaller antibodies' in potential €1.7bn deal
Biologics could be delivered by routes other than injection using nanobodies one tenth the size of an antibody, Ablynx says as it extends its license with Merck & Co.
Pluristem gets German approval for cell therapy manufacturing process
German regulators have approved a 3D manufacturing process that Pluristem Therapeutics claims can produce cell therapies faster and more cheaply than standard methods.